111 related articles for article (PubMed ID: 32910714)
21. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer.
Li P; Zhang Q; Torossian A; Li ZB; Xu WC; Lu B; Fu S
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e391-7. PubMed ID: 22414288
[TBL] [Abstract][Full Text] [Related]
22. Paris Saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest.
Zhao PJ; Song SC; Du LW; Zhou GH; Ma SL; Li JH; Feng JG; Zhu XH; Jiang H
Mol Med Rep; 2016 Mar; 13(3):2878-84. PubMed ID: 26846193
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
24. Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors.
Hashida S; Yamamoto H; Shien K; Ohtsuka T; Suzawa K; Maki Y; Furukawa M; Soh J; Asano H; Tsukuda K; Miyoshi S; Kanazawa S; Toyooka S
Oncol Rep; 2015 Mar; 33(3):1499-504. PubMed ID: 25607753
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.
Russo SM; Tepper JE; Baldwin AS; Liu R; Adams J; Elliott P; Cusack JC
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):183-93. PubMed ID: 11316563
[TBL] [Abstract][Full Text] [Related]
26. Fenofibrate increases radiosensitivity in head and neck squamous cell carcinoma via inducing G2/M arrest and apoptosis.
Liu J; Ge YY; Zhu HC; Yang X; Cai J; Zhang C; Lu J; Zhan LL; Qin Q; Yang Y; Yang YH; Zhang H; Chen XC; Liu ZM; Ma JX; Cheng HY; Sun XC
Asian Pac J Cancer Prev; 2014; 15(16):6649-55. PubMed ID: 25169503
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin.
Chen WS; Lee YJ; Yu YC; Hsaio CH; Yen JH; Yu SH; Tsai YJ; Chiu SJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1527-35. PubMed ID: 20637980
[TBL] [Abstract][Full Text] [Related]
28. SN-38 Acts as a Radiosensitizer for Colorectal Cancer by Inhibiting the Radiation-induced Up-regulation of HIF-1α.
Okuno T; Kawai K; Hata K; Murono K; Emoto S; Kaneko M; Sasaki K; Nishikawa T; Tanaka T; Nozawa H
Anticancer Res; 2018 Jun; 38(6):3323-3331. PubMed ID: 29848680
[TBL] [Abstract][Full Text] [Related]
29. Interaction of ionizing radiation and ZRBA1, a mixed EGFR/DNA-targeting molecule.
Heravi M; Rachid Z; Goudarzi A; Schlisser A; Jean-Claude BJ; Radzioch D; Muanza TM
Anticancer Drugs; 2009 Sep; 20(8):659-67. PubMed ID: 19581798
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer.
Verstraete M; Debucquoy A; Gonnissen A; Dok R; Isebaert S; Devos E; McBride W; Haustermans K
BMC Cancer; 2015 Dec; 15():946. PubMed ID: 26675289
[TBL] [Abstract][Full Text] [Related]
31. The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines.
Miyata H; Sasaki T; Kuwahara K; Serikawa M; Chayama K
Int J Oncol; 2006 Apr; 28(4):915-21. PubMed ID: 16525641
[TBL] [Abstract][Full Text] [Related]
32. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
Raju U; Nakata E; Yang P; Newman RA; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):886-94. PubMed ID: 12377342
[TBL] [Abstract][Full Text] [Related]
33. Combining AZD8931, a novel EGFR/HER2/HER3 signalling inhibitor, with AZD5363 limits AKT inhibitor induced feedback and enhances antitumour efficacy in HER2-amplified breast cancer models.
Crafter C; Vincent JP; Tang E; Dudley P; James NH; Klinowska T; Davies BR
Int J Oncol; 2015 Aug; 47(2):446-54. PubMed ID: 26095475
[TBL] [Abstract][Full Text] [Related]
34. Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity.
Nakata S; Tanaka H; Ito Y; Hara M; Fujita M; Kondo E; Kanemitsu Y; Yatabe Y; Nakanishi H
Int J Oncol; 2014 Oct; 45(4):1583-93. PubMed ID: 25017791
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells.
Moertl S; Payer S; Kell R; Winkler K; Anastasov N; Atkinson MJ
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269745
[TBL] [Abstract][Full Text] [Related]
36. Centipedegrass extract enhances radiosensitivity in melanoma cells by inducing G2/M cell cycle phase arrest.
Kang SH; Bak DH; Chung BY; Bai HW
Mol Biol Rep; 2021 Feb; 48(2):1081-1091. PubMed ID: 33511511
[TBL] [Abstract][Full Text] [Related]
37. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
[TBL] [Abstract][Full Text] [Related]
38. Cyclopamine increases the radiosensitivity of human pancreatic cancer cells by regulating the DNA repair signal pathway through an epidermal growth factor receptor‑dependent pathway.
Wu XY; Che J; Sun KK; Shen XJ; Yang D; Zhong N; Zhao H
Mol Med Rep; 2013 Oct; 8(4):979-83. PubMed ID: 23903906
[TBL] [Abstract][Full Text] [Related]
39. The natural compound gambogic acid radiosensitizes nasopharyngeal carcinoma cells under hypoxic conditions.
Yang M; Yang Y; Cui H; Guan Z; Yang Y; Zhang H; Chen X; Zhu H; Yang X; Cai J; Cheng H; Sun X
Tumori; 2016; 102(2):135-43. PubMed ID: 26357974
[TBL] [Abstract][Full Text] [Related]
40. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]